<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-HT0SEEW8/3e460c28-3b72-4819-aa33-44b033d1d25d/PDF"><dcterms:extent>366 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-HT0SEEW8/7aeeda4f-4348-4eb5-b637-af90ccf9b20c/TEXT"><dcterms:extent>39 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2005-2025"><edm:begin xml:lang="en">2005</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-HT0SEEW8"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-8ER5ZBJN" /><dcterms:issued>2019</dcterms:issued><dc:creator>Kocbek, Petra</dc:creator><dc:creator>Kristl, Julijana</dc:creator><dc:creator>Mirtič, Janja</dc:creator><dc:creator>Zupančič, Špela</dc:creator><dc:format xml:lang="sl">številka:2</dc:format><dc:format xml:lang="sl">letnik:70</dc:format><dc:format xml:lang="sl">str. 162-171</dc:format><dc:identifier>ISSN:0014-8229</dc:identifier><dc:identifier>COBISSID_HOST:4712817</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-HT0SEEW8</dc:identifier><dc:language>sl</dc:language><dc:publisher xml:lang="sl">Slovensko farmacevtsko društvo</dc:publisher><dcterms:isPartOf xml:lang="sl">Farmacevtski vestnik</dcterms:isPartOf><dc:subject xml:lang="sl">Antibiotiki</dc:subject><dc:subject xml:lang="sl">dostavni sistemi</dc:subject><dc:subject xml:lang="sl">nadzorovano sproščanje</dc:subject><dc:subject xml:lang="sl">Nanomateriali</dc:subject><dc:subject xml:lang="sl">Nanotehnologija</dc:subject><dc:subject xml:lang="sl">Parodontalne bolezni</dc:subject><dc:subject xml:lang="sl">Probiotiki</dc:subject><dcterms:temporal rdf:resource="2005-2025" /><dc:title xml:lang="sl">Napredni dostavni sistemi učinkovin za preventivo in zdravljenje parodontalne bolezni| Advanced drug delivery systems for prevention and treatment of periodontal disease|</dc:title><dc:description xml:lang="sl">Periodontal disease causes reduced adhesion of dental tissue to the tooth root, and gradual decomposition of the periodontal ligament, cementum, and alveolar bone, with occasional pain and discomfort on chewing, and eventual tooth loss. This paper provides an update on the approaches to periodontal disease treatment, for reduction of periodontal plaques and periodontopathogenic microorganisms, modulation of immunomodulatory response, and regeneration of periodontal tissues. Advanced delivery systems in the fight against periodontal disease are gaining in importance, and include nanosized carriers for small drug molecules, biopharmaceutics, probiotics, or stem cells. Furthermore, nanodelivery systems with their specific features are designed to improve the bioavailability of the therapeutics over that achieved by conventional dosage forms. Indeed, the nanomedicines can enable targeted drug delivery to periodontal pockets, to specific cells and cellular organelles, or to microorganisms in biofilms. Additionally, the nanocarriers can control the release of the incorporated therapeutic(s). The most studied advanced drug delivery systems for treatment of periodontal disease are liposomes, polymeric nanoparticles, and nanofibers, which are reviewed here. Special focus is on nanofibers, in which can be incorporated drug molecules and probiotics, as well as represent a scaffold for regenerative cells to achieve better regeneration of periodontal tissues in the future</dc:description><dc:description xml:lang="sl">Parodontalna bolezen povzroči zmanjšano adhezijo obzobnih tkiv na zobno korenino in postopno razgradnjo pozobnice, cementa in čeljustne kosti. Ob tem prihaja do bolečine, nelagodja ob žvečenju in izgube zob. V prispevku so predstavljeni danes znani pristopi zdravljenja, kot so odstranjevanje zobnih oblog in parodontopatogenih mikroorganizmov, modulacija imunskega odziva in regeneracija obzobnih tkiv. Pri tem imajo vse večji pomen napredni dostavni sistemi, ki vključujejo nanonosilce, za vnos nizkomolekularnih učinkovin, biofarmacevtikov, probiotikov in matičnih celic. Nanodostavni sistemi v primerjavi s tradicionalnimi farmacevtskimi oblikami izboljšajo terapevtski učinek dostavljenih učinkovin, kar je posledica njihovih edinstvenih lastnosti. Nanozdravila omogočajo ciljano dostavo učinkovin v obzobne žepe, do določenih celic in celičnih organelov ali mikroorganizmov v biofilmu; dodatno pa lahko tudi nadzorujejo sproščanje vgrajenih terapevtikov. Predstavljeni so najpogosteje proučevani napredni dostavni sistemi, kot so liposomi, polimerni nanodelci in nanovlakna za preventivo in zdravljenje parodontalne bolezni. Posebna pozornost je namenjena nanovlaknom, ki omogočajo vgrajevanje učinkovin in probiotikov, lahko pa predstavljajo ogrodje za regenerativne celice za boljšo obnovo obzobnih tkiv v prihodnosti</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-HT0SEEW8"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-HT0SEEW8" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-HT0SEEW8/3e460c28-3b72-4819-aa33-44b033d1d25d/PDF" /><edm:rights rdf:resource="http://rightsstatements.org/vocab/InC/1.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Slovensko farmacevtsko društvo</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-HT0SEEW8/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-HT0SEEW8" /></ore:Aggregation></rdf:RDF>